DUST MANAGEMENT STRATEGY 2002 anglogold DUST FILTRATION 1.

IOHA 2005 Paper S1-2 Silicosis elimination in South Africa D.

Background j)hanghai Health Study Overview ExxonMobil Use Only a.~ ~ Funders: Technical Collaborators: Five-year clinical epidemiology XOM BP ~ Chevron ~ ConocoPhllllps - study to Investigate causes and !"

From: Sent: To: Subject: Cagen, Stuart Z SCC Wednesday, September 12, 2001 3:50 PM (GMT) Tsai, Shan SP SHLOIL-SPS <sptsai@Shel1.Com>; Clegg, Patsy M SCC-CHSE-PC <pmc1egg@Shell.Com> RE: Issues regarding 2nd epi position and the hematopathologist posit ion on the SRP.

To: BenzConsort-OC@listserve.api.org <BenzConsort-OC@listserve.api.org>; BenzConsort-TC@listserve.api.org <BenzConsort-TC@listserve.api.org> From: Russell White <whiter@api.org> Cc: Brenda Hargett <Hargettb@api.org>; Harry Ng <Ng@api.org> Bcc: Received Date: 2007-06-08 18:43:26 GMT Subject: Shanghai Health Study - Oversight Committee conference call - Monday, June 11 at 1 PM EDT There will be a conference call of the BHRC Oversight Committee on Monday, June 11 at 1 PM EDT.

To: BenzConsort-OC@listserve.api.org <BenzConsort-OC@listserve.api.org>; BenzConsort-TC@listserve.api.org <BenzConsort-TC@listserve.api.org> From: Howard Feldman <Feldman@api.org> Cc: Bob Greco <Greco@api.org>; Brenda Hargett <Hargettb@api.org>; Harry Ng <Ng@api.org> Bcc: Received Date: 2007-05-11 01 :59:50 GMT Subject: Fw: UCDHSC Supplemental Proposal ----- Original Message ----From: Sherilyn.Gross@UCHSC.edu To: Howard Feldman Cc: brian.e.doli@exxonmobil.com ; Patsy.Clegg@shell.com ; Myron.c.harrison@exxonmobil.com ; Burnetdm@bp.com Sent: Thu May 1018:00:582007 Subject: UCDHSC Supplemental Proposal o > ear Mr.

From: Sent: To: Cc: Subject: Attach: Matt Todd <ToddM@api.org> Wednesday, December 18, 2002 3:33 PM (GMT) BHRC Technical Committee (E-mail) <benzconsort-tc@api.org> Jim Vail (E-mail)<brec@rockbridge.net> Benzene Health Research Consortium: Ethics Review Panel ethics IT finall.doc Members of the Benzene Health Research Consortium Technical Committee: API is in the process of formalizing the Ethics Review Panel, with Dr.

To: Clegg, Patsy M SCC-CHSE-PC <patsy.clegg@shell.com>; Brian Doll (E-mail) <brian.e.doll@exxonmobil.com>; Burnett, Don (E-mail) <burnetdm@bp.com>; Zach Wong (E-mail) <ZachW ong @chevrontexaco.com> From: Johnston, Michael D.

BUDGET ESTIMATES FOR FINISH STUDY OPTION AND TRANSITION LABORATORY OPTION Cost Centers Original 2007 EOY projection UCHSC Grant Irons-Field Expense Applied Health Sciences Fudan University #REF!

To: From: Cc: Bcc: Received Date: Subject: Brian Doll (E-mail)<brian.e.doll@exxonmobiLcom>; Burnett, Don (E-mail)<burnetdm@bp.com>; Michael Johnston <Mike.d.Johnston@ConocoPhillips.com>; Zach Wong (E-mail)<ZachWong@chevrontexaco.com>; Bruce M.

To: 'Galvin, Jennifer B' <Jennifer.B.Galvin@conocophillips.com>; Bruce Jarnot <j arnotb@api.org>; twerdockl @api.org <twerdockl @api.org> From: Cagen, Stuart Z SCC-CF-SS </O=SHE LUOU=MSXSCC/CN=RE CI PI ENTS/CN=SC724012> Cc: Bcc: Received Date: 2005-01-12 01 :49: 17 GMT Subject: RE: Chair - shanghai TC Great news.

To: Cagen, Stuart Z SCC-HSE <stuart.cagen@shell.com> From: Clegg, Patsy M SCC-CHSE-PC </O=SHE LUOU=MSXSCC/CN=RE CI PI ENTS/CN=PH197432> Cc: Bcc: Received Date: 2004-09-14 11 :58:00 GMT Subject: FW: Shanghai Health Study - Update - Details of call tomorrow Regards, Patsy Patsy Clegg Product Steward Shell Chemical LP One Shell Plaza, 91 0 Louisiana, Houston, TX 77002-4916 Tel: +1 713241 2521 Fax: 3325 Email: patsy.clegg@shell.com Internet: http://www.shell.com/chemicals Attachments: Shanghai Health Study - Update.ZIP SH ELL-MCCLU RG-064595 BEGIN:VCALENDAR PRODID:-IIMicrosoft Corporation//Outlook 9.0 MIMEDIRIIEN VERSION:2.0 METHOD: REQUEST BEGIN:VEVENT ATTENDEE;CN="Clegg, Patsy M SCC-CHSE-PC";ROLE=REQ- PARTICIPANT;RSVP=TRUE:MAILTO:patsy.clegg@shell.com ATTENDEE;CN="Methvin, Stacy P SCC";ROLE=REQ- PARTICIPANT;RSVP=TRUE:MAILTO:Stacy.Methvin@shell.com ATTENDEE;CN="Colquhoun, Bill WA SC-CBLO";ROLE=REQ- PARTICIPANT;RSVP=TRUE:MAILTO:bill.colquhoun@shell.com ATTENDEE;CN="Topiwala, Harshad H SC-CBLO/SCM";ROLE=REQ- PARTICIPANT;RSVP=TRUE:MAILTO:Harshad.Topiwala@shell.com ATTENDEE;CN="Sullivan, Nancy E SCC-CBAR";ROLE=REQ- PARTICIPANT;RSVP=TRUE:MAILTO:nancy.sullivan@shell.com ATTENDEE;CN="Tholstrup, Susan C SCC-HSE";ROLE=REQ- PARTICIPANT;RSVP=TRUE:MAILTO:susan.tholstrup@shell.com ATTENDEE;CN="Smolik, Sam SCC-CHSE";ROLE=REQ- PARTICIPANT;RSVP=TRUE:MAILTO:Sam.Smolik@shell.com ORGANIZER:MAILTO:patsy.clegg@shell.com DTSTART:20040915T110000Z DTEND:20040915T120000Z LOCATION: Teleconference TRANSP:OPAQUE SEQUENCE:O UID:040000008200E00074C5B7101A82E00800000000DOD2EC30D689C401 00000000000000001 00 00000A2E85D2BAFF45149967F2AC6C54D0084 DTSTAMP:20040824T173051 Z DESCRIPTION:The Shanghai Health Study is a major project of Shell\, along with 4 other sponsoring companies (BP\, ChevronTexaco\' ConocoPhillips\, and ExxonMobil)\, to study the potential effects of benzene exposure on human health.

To: 'Russell White' <whiter@api.org> From: Cagen, Stuart Z SHLOIL-SHOIL-SHS </O=SHE LUOU=MSXSCC/CN=RE CI PI ENTS/CN=SC724012> Cc: Bcc: Received Date: 2007-01-0515:10:11 GMT Subject: RE: Shanghai Health Study - Rapid response needed 8th OK, 9th OK except NOT available from 1030 am - 12 noon EST, 10th NOT OK Stuart Cagen, Ph.D.

To: 'Bruce Jarnot' <jarnotb@api.org> From: Cagen, Stuart Z SHLOIL-SHOIL-SHS </O=SHE LUOU=MSXSCC/CN=RE CI PI ENTS/CN=SC724012> Cc: Bcc: Received Date: 2007-06-0720:07:28 GMT Subject: RE: BPSC...

To: Snyder, Phil J SCC-DCS/2 <phil.snyder@shell.com> From: Clegg, Patsy M SCC-DCS/22 </O=SHE LUOU=MSXSCC/CN=RE CI PI ENTS/CN=PH197432> Cc: Bcc: Received Date: 2007-03-06 13:28: 17 GMT Subject: FW: Clarification - NOTE FROM IRONS -----Original Message----From: Richard.lrons@UCHSC.edu [mailto:Richard.lrons@UCHSC.edu] Sent: Tuesday, March 06, 2007 2:04 AM To: brian.e.doll@exxonmobil.com; Clegg, Patsy M SCC-DCS/22; Jennifer.B.Galvin@conocophillips.com; Burnetdm@bp.com; michael.g.bird@exxonmobil.com Subject: Clarification To: Members of the Benzene Health Consortium From: Richard Irons Date: March 6, 2007 On February 28th I returned to China, acting in good faith after being advised in your February 23rd letter that the Benzene Health Research Consortium had unanimously approved my proposal for a funding extention on January 29th, 2007.